162 related articles for article (PubMed ID: 1693313)
1. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
Keegan-Rogers V; Wu GY
Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
[TBL] [Abstract][Full Text] [Related]
2. Targeted antagonism of galactosamine toxicity in normal rat hepatocytes in vitro.
Wu GY; Keegan-Rogers V; Franklin S; Midford S; Wu CH
J Biol Chem; 1988 Apr; 263(10):4719-23. PubMed ID: 3350810
[TBL] [Abstract][Full Text] [Related]
3. Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.
Cawley DB; Simpson DL; Herschman HR
Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3383-7. PubMed ID: 6167984
[TBL] [Abstract][Full Text] [Related]
4. Model for specific rescue of normal hepatocytes during methotrexate treatment of hepatic malignancy.
Wu GY; Wu CH; Stockert RJ
Proc Natl Acad Sci U S A; 1983 May; 80(10):3078-80. PubMed ID: 6190170
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated transport of oligodeoxynucleotides into hepatic cells.
Reinis M; Damková M; Korec E
J Virol Methods; 1993 Apr; 42(1):99-105. PubMed ID: 7686560
[TBL] [Abstract][Full Text] [Related]
6. Targeting of mitomycin C to the liver by the use of asialofetuin as a carrier.
Kaneo Y; Tanaka T; Iguchi S
Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):999-1003. PubMed ID: 1716529
[TBL] [Abstract][Full Text] [Related]
7. Acetaminophen hepatotoxicity and targeted rescue: a model for specific chemotherapy of hepatocellular carcinoma.
Wu GY; Wu CH; Rubin MI
Hepatology; 1985; 5(5):709-13. PubMed ID: 2993145
[TBL] [Abstract][Full Text] [Related]
8. Cystamine modulation of galactosamine-induced hepatotoxicity.
MacDonald JR; Gandolfi AJ; Sipes IG
Toxicol Appl Pharmacol; 1984 May; 73(3):551-8. PubMed ID: 6719469
[TBL] [Abstract][Full Text] [Related]
9. In vivo quantification of receptor-mediated uptake of asialoglycoproteins by rat liver.
Pardridge WM; Van Herle AJ; Naruse RT; Fierer G; Costin A
J Biol Chem; 1983 Jan; 258(2):990-4. PubMed ID: 6185482
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
Drevon CA; Tolleshaug H; Carlander B; Berg T
Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
[TBL] [Abstract][Full Text] [Related]
11. Uptake and degradation of asialo-orosomucoid in hepatocytes from carcinogen-treated rats.
Schwarze E; Tolleshaug H; Seglen O
Carcinogenesis; 1985 May; 6(5):777-82. PubMed ID: 4006062
[TBL] [Abstract][Full Text] [Related]
12. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor.
Dini L; Autuori F; Lentini A; Oliverio S; Piacentini M
FEBS Lett; 1992 Jan; 296(2):174-8. PubMed ID: 1370803
[TBL] [Abstract][Full Text] [Related]
13. In vivo depletion of mannose receptor bearing cells from rat liver by ricin A chain: effects on clearance of beta-glucuronidase.
Simmons BM; Stahl PD; Russell JH
Biochem Biophys Res Commun; 1987 Jul; 146(2):849-54. PubMed ID: 2441698
[TBL] [Abstract][Full Text] [Related]
14. Galactose-particle receptor on liver macrophages. Quantitation of particle uptake.
Teradaira R; Kolb-Bachofen V; Schlepper-Schäfer J; Kolb H
Biochim Biophys Acta; 1983 Sep; 759(3):306-10. PubMed ID: 6192849
[TBL] [Abstract][Full Text] [Related]
15. Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin.
Simpson DL; Cawley DB; Herschman HR
Cell; 1982 Jun; 29(2):469-73. PubMed ID: 6180832
[TBL] [Abstract][Full Text] [Related]
16. An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents.
Bader A; Reimer P; Knop E; Böker K; Christians U; Weissleder R; Sewing KF
Magn Reson Imaging; 1995; 13(7):991-1002. PubMed ID: 8583878
[TBL] [Abstract][Full Text] [Related]
17. The influence of cellular ATP levels on receptor-mediated endocytosis and degradation of asialo-glycoproteins in suspended hepatocytes.
Tolleshaug H; Kolset SO; Berg T
Biochem Pharmacol; 1985 May; 34(10):1639-45. PubMed ID: 2408622
[TBL] [Abstract][Full Text] [Related]
18. The rat hepatic corticosteroid-binding globulin receptor: distinction from the asialoglycoprotein receptor.
Maitra US; Khan MS; Zhang XH; Rosner W
Endocrinology; 1990 Jul; 127(1):278-84. PubMed ID: 1694492
[TBL] [Abstract][Full Text] [Related]
19. Specific targeting of the antiviral drug 5-iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine.
Biessen EA; Beuting DM; Vietsch H; Bijsterbosch MK; Van Berkel TJ
J Hepatol; 1994 Nov; 21(5):806-15. PubMed ID: 7890898
[TBL] [Abstract][Full Text] [Related]
20. Studies on the liver sequestration of lymphocytes bearing membrane-associated galactose-terminal glycoconjugates: reversal with agents that effectively compete for the asialoglycoprotein receptor.
Samlowski WE; Spangrude GJ; Daynes RA
Cell Immunol; 1984 Oct; 88(2):309-22. PubMed ID: 6207941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
